Stock News & Analysis

These all have attractive yields and long track records of reliability.

Nvidia has a good problem on its hands: what to do with all this excess capital.

SCHF's lower costs and higher dividend yield make it attractive for cost-conscious investors seeking developed market exposure.

They are both profiting from the AI boom, but one of them looks more attractive right now.

On Oct. 8, 2026, rising Treasury yields and higher oil prices weigh on equities as investors reassess rate expectations.

That massive spending plan could be justified by rapidly growing revenue, but the AI lab has little room for error.

BioNTech's cancer pipeline is bigger than its COVID-era reputation suggests, and the stock still trades below $100.

The medical device giant deserves a lot more attention.

Two tech titans are folding AI into the products billions already use, and that's exactly what makes them built to last.

Nebius and CoreWeave are growing at incredible rates.

Does Chainlink's CCIP 2.0 upgrade matter for LINK holders? It could, but the big banks need to show up first.

Eli Lilly's obesity lead is only the starting point. See what its pipeline, manufacturing build-out, pricing pressure, and earnings trajectory could mean for the stock's next chapter.

This popular valuation metric is essentially at its highest level ever.

There are good reasons not to jump on board with quantum computing stocks just yet.

Tariff refunds lift Helen of Troy stock to an earnings beat.

Two air taxi pioneers are racing toward commercial flight, each with a distinct risk-reward profile worth watching closely.

The specialty pharmaceutical company is being acquired.

This 175-year-old glassmaker is now at the center of the artificial intelligence boom.

AGNC's 17% yield looks tempting, but investors should review its total returns.

Micron's latest quarterly report was a winner, and there's another big catalyst on the horizon.